Halper Sadeh 调查了 Repare Therapeutics 与 XenoTherapeutics 就公平和信托义务达成的每股 1.82 美元交易。 Halper Sadeh investigates Repare Therapeutics' $1.82/share deal with XenoTherapeutics over fairness and fiduciary duties.

Halper Sadeh LLC已对Repare治疗公司提出的与Xeno治疗公司每股现金交易1.82美元的提议展开调查,其中包括与未来伙伴关系付款挂钩的不可转让或有价值权利。 Halper Sadeh LLC has launched an investigation into Repare Therapeutics' proposed $1.82 per share cash deal with XenoTherapeutics, including non-transferable contingent value rights tied to future partnership payouts. 调查的重点是Repare的董事会是否履行了信托义务,如果报价公平,如果对竞争性投标或内幕利益的限制损害股东价值。 The probe focuses on whether Repare’s board fulfilled fiduciary duties, if the offer is fair, and if restrictions on competing bids or insider benefits undermine shareholder value. 该公司在应急基础上为投资者寻求更好的条件,不预付任何费用。 The firm is seeking better terms for investors on a contingency basis with no upfront cost.